Homepage
zurück
Inhaltsverzeichnis
zurück
empfohlener webshop
 

LITERATUR

Die zitierten Literaturstellen beziehen sich sowohl auf Originalarbeiten als auch auf Übersichtsartikel (Review Literature) über Vitamin C.

1. Altmann P. et al.: Über die entbleiende Wirkung einer kombinierten Therapie mit Calcium-phosphat und Vitamin C bei erhöhter Bleibelastung in der Schwangerschaft. 1981, Wien. Med. Wschr. 131/311-314
2. Amburgey C.F. et al.: Undernutrition as risk factor for cervical intraepithelial neoplasia: A case-control analysis. 1993, Nutrition and Cancer 20(1) p. 51-60
3. Anderson R.: Ascorbase-mediated stimulation of neutrophil motility and lymphocyte transformation by inhibition of peroxidase-H2O2-halide system in vitro and in vivo. American Journal of Clinical Nutrition 1981; 34:1906-1911; Anderson R. (1982): Effects of ascorbate on normal and abnormal leucocyte functions, in vitamin C. New Clinical Applications in Immunology, Lipid Metabolism, and Cancer. Hrsg. A.Hanck, S.23-34; Panush R.S.; Delafuente J.C., Katz P., Johnson J.: Modulation of certain immunologic responses by vitamin C. III. Potentiation of in vitro and in vivo lymphocyte responses, in vitamin C. New Clinical Applications in Immunology, Lipid Metabolism, and Cancer. Hrsg. A.Hanck: Hans Huber, Bern, 1982; S.35-47
4. Anderson E.: Effects of ascorbite on normal and abnormal leucocyte functions. Int. J. Vit. Nutr. Res. 1982; 23 (Suppl): 23-34
5. Anderson R.: Ascorbase-mediated stimulation of neutrophil motility and lymphocyte transformation by inhibition of peroxidase-H2O2-halide system in vitro and in vivo. American Journal of Clinical Nutrition 1981; 34:1906-1911; Anderson R.: Assessment of oral ascorbate in three children with chronic granulomatour disease and defective neutrophil motility over a two-year period. Clinical and Experimental Immunology 1981; 43:180-188
6. Anderson R.: Assessment of the roles of vitamin C, vitamin E, and ß-carotene in the modulation of oxidant stress medicated by cigarette smoke-activated phagocytes. Am. J. Clin. Nutr. 1991; 53: 358-361
7. Anderson T.W.: Large scale trials of vitamin C in the prevention and treatment of common cold. Acta vitaminol. Enzymol. 1974; 28: 99-100
8. Anthony H.M., Schorah C.J.: Severe hypovitaminosis C in lung cancer patients: the utilization of vitamin C in surgical repair and lymphocyte-related host resistance. Br. J. Cancer 1982; 46: 354-367
9. Ärzte Zeitung vom 8.4.1997
10. Asfora J.: Vitamin C in high dosis in the treatment of the common cold. In: Re-evaluation of Vitamin C. Hanck A., Ritzel G. Bern 1977
11. Asper R., Schmucki O.: Fortschr. Urol. Nephrol. 1981; 17: 422.
12. Barr D.P., Russ E.M., Eder H.A.: Protein-lipid relationship in human plasma. II. In atherosclerosis and related conditions. American Journal of Medicine 1951; 11:480-493
13. Bartley W. et al.: Vitamin C requirement of human adults. A report by the vitmain C subcommittee of the accessory food factors committee. Med. Res. Council Spec. Rep. Ser. 1953; 280 HMSO, London
14. Bassenge E., Fink B.: Tolerance to nitrates and simultaneous upregulation of plateled activity prevented by enhancing antioxidant state. Arch. Pharmacol. 1996; 353: 363-367
15. Basu T.K. et al.: Leukocyte ascorbic acid and urinary hydroxyproline levels in patients bearing breast cancer with skeletal metastasis. Europ. J. Cancer 1974; 10: 507-511
16. Basu T.K.: The influence of drugs with particular reference to aspirin on the bioavailability of vitamin C. In: Vitamin C. Counsell, J.N., Hornig, D.H. Applied Science Publishers London 1981
17. Bayer W., Schmidt K.: Vitamine in Prävention und Therapie. Hippokrates Verlag GmbH, Stuttgart 1991; 252
18. Bieber L.L. et al.: Possible functions of short-chain and medium-chain carnitine acyltransferases. Fed. Proc. 1982; 41: 2858-2862
19. Biesalski, Fürst, Kasper, Kluthe, Pölert, Puchstein, Stähelin: Ernährungsmedizin. 1999, Georg Thieme Verlag Stuttgart
20. Biesalski H.K., Frank J.: Antioxidanzien in der Ernährung und ihre Bedeutung für die anti-/prooxidative Balance im Immunsystem. Immun. Infekt. 1995; 23, 5: 166-172
21. Bietti G.B.: Further contributions on the value of osmotic substances as means to reduce intra-ocular pressure. Ophthalmological Society of Australia 1967; 26:61-71
22. Bjelke E.: Epidemiologic studies of cancer of the stomach, colon and rectum. Dissertation, University of Minnesota; Bjelke, E.: Epidemiologic studies of cancer of the stomach, colon and rectum with special emphasis on the role of diet. Scandienavian Journal of Gastroenterology 9 (Zusatz 31:) 1974; 1-235
23. Block G.: Epidemiologic evidence regarding vitamin C and cancer. 1991, Amer .J. Clin. Nutr. 54 Suppl. 6 / 1310S-1314S
24. Block G.: Vitamin C status and cancer: epidemiologic evidence of reduced risk. Ann. N. Y. Acad. Sci. 1992; 669: 280-292
25
. Blumberg J.B.: Considerations of the scientific substantiation for antioxidant vitamins and beta-carotene in disease prevention. Am. J. Clin. Nutr. 1995; 62, 6 (Suppl): 1521-1526
26
. Boissevain C.H., Spillane J.H.: Effect of synthetic ascorbic acid on the growth of tuberculosis bacillus. American Review of Tuberculosis 1937, 35:661-662
27. Briggs M.: Vitamin C requirement and oral contraceptives. 1972, Nature 238:277
28. Brock K.E. et al.: Nutrients in diet and plasma and risk of in situ cervical cancer. 1988, Journal of the National Cancer Institute, 80(8) June 15, p. 580-585
29. Broquist H.P.: Carnitine biosynthesis and function. Fed. Proc. 1982; 41:2840-2842

30. Brubacher G., Schlettwein-Gsell D.: Untersuchungen über die Vitaminversorgung alter Menschen. Aktuelle Gerontologie 1971; 1: 461-467
31. Buettner G.R., Jurkiewicz B.A.: Catalytic metals, ascorbate and free radicals: combinations to avoid. Radiat. Res. 1996; 145, 5: 532-541
32. Burr M.L., Samloff I.M., Bates C.J.: Atrophic gastritis and vitamin C status in two towns with different stomach cancer death-rates. Br. J. Cancer 1987; 56:163
33. Burr R.G., Rajan K.T.: Leukocyte ascorbic acid and pressure sores in paraplegia. 1972, British Journal of Nutrition 28:275-281
34. Bussey H.J. et al.: A randomized trial of ascorbic acid in polyposis coli. 1982, Cancer, 50(7) October 1982, p. 1434-1439
35. Buzina R. et al.: Increase of gingival hydroxyproline and proline by improvement of ascorbic acid status in man. Int. J. for Vitamin C and Nutr. Res. 1986; 56:#4, 367-372
36. Cameron E., Pauling L.: Cancer and vitamin C. 1993, Canino Books Philadelphia
37. Cameron E., Pauling L.: Supplemental ascorbate in the supportive treatment of cancer: Reevaluation of prolongation of survival times in terminal human cancer. Proc. Natl. Acad. Sci. (USA) 1978; 75:4538-4542
38. Cameron E.: Biological function of ascorbic acid and the pathogenesis of scurvy. Medical Hypotheses 1976; 2:154-163
39. Cathcart R.F.: Vitamin C, titrating do bowel tolerance, anascorbemia, and acute induced scurvy. Medical Hyphotheses 1981, 7:1359-1376
40. Chamiec T.,Herbaczynska-Cedro K., Ceremuzynski, L.: Effects of antioxidant vitamin C and E on signal-averaged electrocardiogram in acute myocardial infarction. Am. J. Cardiol. 1996; 77, 4: 237-241
41. Chen L.H. et al.: Vitamin C, vitamin E and cancer. 1988, Anticancer Research, 8(4), July-August, p. 739-748
42. Cheraskin E., Ringsdorf W.M., Medford FH.: Daily vitamin consumption and fatigability. 1976, Journal of the American Geriatrics Society 24: 3/136-137
43. Cheraskin E., Ringsdorf W.M.jr., Sisley E.L.: The vitamin C connection. 1983; Harper and Row, New York.
44. Cheraskin E.W.M. et al.: A relationship between vitamin C intake and electrocardiography. 1979, J.Electrocardiol. 12:441
45. Chope H.D., Breslow L.: Nutritional status of the aging. 1955, American Journal of Public Health 46:61-67
46. Chow C.K., Thacker R.R., Changcit C.: Lower levels of vitamin C and carotenes in plasma of cigarette smokers. J. Am. Coll. Nutr. 1986; 5: 305-12
47. Church J.P. et al.: Relationship among dietary constituents and specific serum clinical components of subjects eating self-selected diets. 1984, Amer. J. Clin. Nutr. 40:1338-1344
48. Clemetson C.A.B.: Histamine and ascorbic acid in human blood. Journal of Nutrition 1980; 110:662-668
49. Cooper K.H.: Die neuen Gesundmacher Antioxidantien. BLV Verlagsgesellschaft mbH München, Wien, Zürich 1994
50. Cox B.D., Butterfield W.J.H.: Vitamin C supplements and diabetic cutaneous capillary fragility. 1975, British Medical Journal 3:#5977, 205-207
51. Crandon J.H., Lennihan R. jr., Mikal S., Reif A.E.: Ascorbic acid economy in surgical patients. 1961, Annals of the New York Academy of Sciences 92:246-267
52. Davie S.E. et al.: Effect of vitamin C glycosilation of proteins. 1992, Diabetes 41:167-173
53. Deana R. et al.: Changes relevant to catecholamine metabolism in liver and brain of ascorbic acide deficient guinea-pigs. Int. J. Vit. Nutr. Res. 1975; 45/175-182
54. DeChatelet L.R., McCall C.E.: 1974, Proc. Soc. Exp. Biol. Med. 145:1170 und Goetzl E.J. et al. in J. Clin. Invest. 1974 53:813
55. Diabetes 11.1.2000
56. Diplock A.T.: Safety of antioxidant vitamins and beta-carotene. Am. J. Clin. Nutr. 1995; 62, 6 (Suppl): 1510-1516
57. Do B.K., Garewal Q., Clements H.S., Peng N.C., Habib M.P.: Exhaled ethan and antioxidant vitamin supplements in active smokers. Chest 1996; 110, 1: 159-64
58. Dorgan J.F., Schatzkin A.: Antioxidant micronutrients in cancer prevention. Hematol./Oncol. Clin. North Am. 1991; 5, 1:43-68
59. Eichholzer M. et al.: Inverse correlation between essential antioxidants in plasma and subsequent risk to develop cancer, ischemic heart disease and stroke respectively: 12-year follow-up of the Prospective Basel Study. 1992, EX3, 62, p. 398-410
60. Elias M.: Changing concepts of nutrient requirements in disease: implications for artificial nutritional support. Lancet 1995; 345:1279-1284
61. Engel-Apotheke Basel: Orthomolekulare Medizin: Vitamin C. 1998, Nr. 10, 10.10.98 12. Jahrgang
62. Enstrom J.E. et al.: Vitamin C intake and mortality among a sample of the United States population. Epidemiology 1992; 3/ 194-202
63. Enström J.E., Kanim L.E., Klein M.A.: Vitamin C intake and mortality among a sample of the United States population. Epidemiology 1992; 3:194-202
64. Eye Disease Case-Control Study Group: Antioxidant status and neovascular age related macular degeneration. Archives of Ophthalamology 1993; 111:#1, 104-109
65. FAZ Frankfurt vom 25.9.1996: Bezug: Proceedings Nat. Acad. of Science Bd. 93, S.9970
66. Ferraroni M. et al.: Selected micronutrient intake and the risk of colorectal cancer. 1994, British Journal of Cancer, 70(6) December 1994, p.1150-1155
67. Fidanza A. et al.: Vitamin C and cholesterol. Int. J. Vit. Nutr. Res. 1982; 23: 153-171
68. Food and Nutrition Board, National Academy of Sciences: Recommended dietary allowances, 10th ed. National Academy Press Washington, DC 1989
69. Fox M.R. et al.: Effects of vitamin C and iron on cadmium metabolism. Ann. N. Y. Acad. Sci. 1980; 355:249-261
70. Frei B.B., Ames N.: Ascorbic acid protects plasma lipids against oxidative damage. Nutr. and Cancer 1991; 15/250-251
71. Friedrich W.: Handbuch der Vitamine. 1987; Urban & Schwarzenberg, München
72. Fueßl H..: Der Gastrointestinaltrakt ö Ein endokrines Organ. 1988, Med..Mo..Pharm. 11(8) 270-75
73. Fullmer H.M., Martin G.R., Burns J.J.: Role of ascorbic acid in the formation and maintenance of dental structures. Annals of the New York Academy of Science 1961; 92:286-294
74. Gabel R.A. et al.: Hereditary methemoglobinemia as a cause of cyanosis during anesthesia. 1974, Anesthesiology 40:516-518
75. Gabel R.A., Bunn H.F..: Hereditary methemoglobinemia as a cause of cyanosis during anesthesia. Anesthesiology 1974; 40: 516-518
76. Gale L.R. et al.: Vitamin C and risk of death from stroke and coronary heart disease in cohort of elderly people. Br..J. Med. 1995; 310/1563-1566
77. Gander J., Niederberg W.: 1936, Münch. Med. Wochenschr. 83:1386
78. Gembal M., Druzynska J., Kowalczyk M., Przepiera E., Cybal M., Arendarczyk W., Wojcikowski CZ.: The effect of ascorbic acid on protein glycation in streptozotocin-diabetic rats.
79. Gey K.F., Brubacher G.B., Stahelin H.B..: Plasma levels of antioxidant vitamins in relation to ischemic heart disease and cancer. Am. J. Clin. Nutr. 1987; 45:1368
80. Gey K.F., Moser U.K., Jordan P., Staehelin H.B., Eichholzer M., Luedin E.: Increased risk of cardiovascular disease at suboptimal plasma concentrations of essential antioxidants: an epidemiological update with special attention to carotene and vitamin C. Am. J. Clin. Nutr. 1993; 57, 5 (Suppl): 787-797
81. Ginter E. et al.: Effect of ascorbic acid on plasma cholesterol in humans in a long-term-experiment. Int. J. Vit. Nutr. Res. 1977; 47: 123-134
82. Ginter E., Bobek P.: The influence of vitamin C on lipid metabolism. In: Vitamin C. Counsell J.N., Hornig D.H. Applied Science Publishers London 1981
83. Goetzel E.J., Wassermann S.I., Gigli I., Austen K.F.: Enhancement of random migration and chemotactic response of human leukocytes by ascorbic acid. J. Clin. Invest. 1974; 53:813-818
84. Goldie J. et al.: Ascorbic acid inhibits the growth and activity of Campylobacter pylori. 1989, Gut 30:1484
85. Gorozhanskaia E.G., et al.: The role of ascorbic acid in the combined preoperative preparation of cancer patients. 1989, Vopr Onkol., 35 (4), p. 436-441
86. Greenfield N. et al.: Activation and inhibition of the adrenal steroid 21-hydroxylation system by cytosolic constituents: influence of glutathione, glutathione reductase, and ascorbate. Arch. Biochem. Biophys. 1981; 200: 232-244.
87. Greenwood J.: Optimum vitamin C intake as a factor in the preservation of disc integrity. Medical Annals of the District of Columbia 1964; 33:274-276
88. Griffiths L.L.: Vitamins and the elderly. 1968, Briston Wright, England
89. Guzek G.: Das Pillenwunder. Manager Magazin 1995; November
90. Hagler L., Herman R.H.: Oxalate metabolism. Am. J. Clin. Nutr. 1973; 26: 758-765
91. Hahn A.: Wirkungen von Pharmaka auf den Stoffwechsel der Nährstoffe. Deutsche Apotheker Zeitung 1994; 134, 50: 4975-4987
92. Hallberg L., Brune M., Rossander-Hulthon L.: Is there a physiological role von vitamin C in iron absorption? In: Bruns, Rivers, Machlin: Third Conference on Vitamin C. Ann. N.Y. Acad. Sci. 1987; 498/324-332
93. Hallberg L.: Effect of vitamin C on the biovailability of iron from food. In: Counsell J.N., Hornig D.H.: Vitamin C (Ascorbic Acid) 1981; Applied Science, London
94. Harris W.A., Harden T.E., Dawson E.B.: Apparent effect of ascorbic acid medication on semen metal levels. Fertility and Sterility 1979, 32:#4, 455-459
95. Hennekens C.H., Gaziano J.M., Manson J.E., Buring J.E.: Antioxidant vitamin-cardiovascular disease hypothesis is still promising, but still unproven: the need for randomized trials. Am. J. Clin. Nutr. 1995; 62, 6 (Suppl): 1377-1380
96. Herrero R., et al.: A case-control study of nutrient status and invasive cervical cancer: I. Dietary Indicators. 1991, Amer.J. of Epidemiology, 134 (11) December 1, p. 1335-1345
97. Heseker H.: Antioxidative Vitamine und Katarakte im Alter. Zeitschrift für Ernährungswissenschaft 1995; 34, 3:167-176
98. Hilsted L. et al.: Impaired a-carboxyamidation of gastrin in vitamin C-deficient guinea pigs. FEBS Letters 1986; 196:151-154
99. Hornig D., Weiser, H.: Ascorbic acid and cholesterol: effect of graded oral intakes on cholesterol conversion to bile acid in guinea-pigs. Experienta 1976; 32: 687-689
100. Hornig D.H., Glatthaar B.E.: Vitamin C and smoking: Increased requirement of smokers. In: Vitamins: Nutrients and therapeutic agents. Hanck, A., Hornig, D. Hans Huber Publishers, Bern 1985
101. Horrobin D.F., Oka M., Manku M.S.: The regulation of prostaglandin E1 formation: A candidate for one of the fundamental mechanisms involved in the cctions of vitamin C. Medical Hypotheses 1979; 5:849-858
102. Horrobin D.F., Manku M.S., Oka M., Morgan R.O., Cunnane S.C., Ally A.L., Ghayur T., Schweitzer M., Karmali R.A.: The nutrinational regulation of T-lymphocyte function. Medical Hypotheses 1979; 5:969-985
103. Howe G.R., et al..: Dietary factors and the risk of breast cancer: Combined analysis of 12 case-controlled studies. 1992, Journal of the National Cancer Institute, 82, p. 561-569
104. Hume R.. et al.: Ascorbate status and fibrinogen concentrations after cerebrovascular accident. J. Clin. Pathol. 1982; 35/195-199
105. Hume R., Weyers E.: Changes in leucocyte ascorbic acid during the common cold. Scottish Medical Journal 1973; 18:3-7
106. Jacob R.A., Burri B.J.: Oxidative damage and defense. Am. J. Clin. Nutr. 1996; 63, 6:985-990
107. Jacques P. et al.: Ascorbic acid, HDL, and total plasma cholesterol in the elderly. 1987, J. Amer .Coll. Nutr. 6:169-174
108. Jacques P.F., Chylac L.T.: Epidemiologic evidence of a role for the antioxidant vitamins and carotenoids in cataract prevention. Amer. Journ. of Clinical Nutrition 1991; 53:3520 S - 3525 S
109. Jacques P.F., Halpner A.D., Blumberg J.B.: Influence of combined antioxifdant nutrient intakes on their plasma concentrations in an elderly population. Am. J. Clin. Nutr. 1995; 62: 1228-1233
110. Jacques P.F.: Relationship of vitamin C status to cholesterol and blood pressure. Anals of the New York Academy of Sciences 1992; 669:205-214
111. James M.J. et al.: Kinetics of carnitine uptake by rat epididymal cells. Androgen-dependence and lack of stereospecifity. FEBS Letters 1981; 126:153-156
112. Jarosz M. et al.: Effects of high dose vitamin C treatment on heliobacter pylori infection and total vitamin C concentration in gastric juice. 1997; WHO Collaborating Centre of Nutrition
113. Jialal I., Fuller C.J.: Effect of vitamin E, Vitamin C and beta-carotene on LDL oxidation and atherosclerosis. Canad. J. Cardiol. 1995; 11, (Suppl G): 97-103
114. Jimi S., Saku K., Uesugi N., Sakata N., Takebayashi, S.: Oxidized low density lipoprotein stimulates collagen production in cultured arterial smooth muscle cells. Atherosclerosis 1995; 116, 1:15-26
115. Journal für Orthomolekulare Medizin, 1999; 1/99 Ralf Reglin Verlag, Köln
116. Jungeblut C.W.: Inactivation of poliomyelitis virus by crystalline vitamin C (ascorbit acid). Journal of Experimental Medicine, 1935, 62:517-521
117. Karlson P., Doenecke D., Koolman J.: Kurzes Lehrbuch der Biochemie für Mediziner und Naturwissenschaftler. Georg Thieme Verlag Stuttgart, New York, 1994
118. Klein F. et al.: Unchanged renal haemodynamics following high dose ascorbic acid administration in IDDM patients. Scand. J. Clin. Lab. Invest 1995; 55:3-59
119. Klenner F.R.: Observations on the dose and administration of ascorbic acid when employed beyond the range of a vitamin in human pathology. J. Appl. Nutr. 1971; 23: 61-88
120. Klenner F.R.: Virus pneumonia and its treatment with vitamin C. Journal of Southern Medicine and Surgery 1948, 110:60-63; Klenner F.R.: Observations on the dose and administration of ascorbic acid when employed beyond the range of a vitamin in human pathology. Journal of Applied Nutrition 1971, 23:61-88; Mc Cormick W.J.: Ascorbic acid as a chemotherapeutic agent. Archives of Pediatrics 1952, 69:151-155
121. Knaak D., Podleski T.: Ascorbic acid mediates acetylcholine receptor increase induced by brain extract on myogenetic cells. Proc. Natl. Acad. Sci. USA 1985; 82/575-579
122. Kratzing C.C. et al.: Ascorbic acid in neural tissues. J. Neurochem. 1982; 39: 625-627
123. Kromhout D.: Essential micronutrients in relation to cancerogenesis. Am. J. Clin. Nutr. 1987; 45:1361
124. Krumdieek C. et al.: Ascorbate-cholesterol-lecithin interactions: factors of potential importance in the pathogenesis of atherosclerosis. 1974, Amer. J. Clin. Nutr. 27:866-876
125. Kubala A.L., Katz M.M.: Nutritional factors in psychological test behavior. 1960, Journal of Genetic Psychology 96:343-352
126. Kuklinski B., van Lunteren I.: Neue Chancen zur natürlichen Vorbeugung und Behandlung von umweltbedingten Krankheiten. Zellschutz mit Anti-Oxidantien. 1995; LebensBaum Verlag, Bielefeld
127. Küpper C.: Oxidativer Streß: Immunsystem braucht gute Balance. Fortschr. Med. 1996; 114, 8: 10-12
128. La Vecchia C., et al.: Selected micronutrient intake and the risk of gastric cancer. 1994, Cancer Epidemiol Biomarkers Prevention, 3(5), July-August, p. 393-398
129. Levine M., Rumsey S., Wang Y., Park J., Kwon O., Xu W., Amano N.: Vitamin C. In: Present knowledge in nutrition. Seventh Edition. E.E. Ziegler und L.J. Filer. ILSI Press Washington, DC 1996
130. Littarru G.P..: Energie und Schutz. Coenzym Q 10: Fakten und Perspektiven in der Biologie und Medizin. C.E.S.L.srl Rom 1995
131. Lunec Blake, J.: The determination of dehydroascorbic acid and ascorbic acid in the serum and synovial fluid of patients with rheumatoid arthritis. 1985, Free Radical Research communications, Vol 1, No. 1, pp 31-39
132. Masaki K.H. et al.: 2000, Neurology 54:1265
133. Matschurat Th.: Orthomolekulare Supplemente: Ihre Wirkung auf das Immunsystem. Naturheilpraxis 1997; 09/1997 1392-1398
134. McAlindon T.E., et al.: Do antioxidant micronutrients protect against the development and progression on knee osteoarthritis? 1996, Arthritis and Rheumatism, 39, 648
135. McLaughlin J.K., Gridley G., Block G.: Dietary factors in oral and pharyngeal cancer. J. Natl. Cancer Inst. 1988; 80:1237
136. Mefford M. et al.: Regional distribution of ascorbate in human brain. Brain Res. 1981; 212/223-226
137. Mehra M.R., Lavie C.J., Ventura H.O., Milani R.V.: Prevention of atherosclerosis. The potential role of antioxidants. Postgrad. Med. 1995; 98, 1:175-176
138. Mettlin C., Graham S., Priore R.: Diet and cancer in esophagus. Nutr. Cancer 1980; 2:143.
139. Milius M. et al.: In vitro inhibition of heliobacter pylori urease: biochemical and ultrastructural analysis. 1991, Eur.J.Clin. Invest. 21:551-7
140. Miller N.E., Förde O.H., Thelle D.S., Mjös O.D.: The tromso heart study: High-density lipoprotein and coronary heart disease, a prospective case-control sStudy. The Lancet 1977; 1:965
141. Mink K.A. et al.: Amelioration of rhinovirus colds by vitamin C (ascorbic acid) supplementation. In: Medical virology VIII. De la Maza, L.M. Elsevier 1988
142. Mirvish S.S.: Letters to the editor: Vitamin C inhibition of N-Nitroso compound formation. 1993, Amer. J. Clin. Nutr. 57, p. 598-599
143. Moffat L., et al.: High dose ascorbate therapy and cancer, 1983, NFCR Cancer Research Association Symposium, (2) p. 243-256
144. Moriarty MJJ., et al.: 1977, Ir. J. Med. Sci. 146:74
145. Morishige F., Murata A.: Vitamin C for prophylaxis of viral hepatitis B in transfused patients. Journal of the International Academy of Preventive Medicine 1978, 5:54-58
146. Morton D.J. et al.: 1997, Department of Family and Preventive Medicine, University of California, San Diego
147. Mukherjee D., Som S., Chatterjee I.B.: Ascorbic acid metabolism in trauma. 1982, Indian Journal of Medical Research 75:748-751148. Murad S., Grove D., Lindberg K.A., Reynolds G., Sivarajah A., Pinnel S.R.: Regulation of collagen synthesis by ascorbic acid. 1981, Proceedings of the National Academy of Scienses USA 78:2879-2882; Murad S., Tajima S., Johnson G.R., Sivarajah A., Pinnel S.R.: Collagen Synthesis in Cultered Human Skin Fibroblasts: Effect of Vitamin C and its Analogs. 1983, Journal of Investigative Dermatology 81:158-612
149. Murata A. et al.: Prolongation of survival times of terminal cancer patients by administration of large doses of ascorbate. Int. J. Vit. Nutr. Res. (Suppl) 1982; 23: 103-113
150. Murata A., Kitagawa K., Saruno R.: Inactivation of bacteriophages by ascorbic acid. Agricultural and Biological Chemistry 1971, 35:294-296; Murata A., Kitagawa K.: Mechanism of inactivation of bacteriophage J1 by ascorbic acid. Agricultural and Biological Chemistry 1973, 35:1145-1151; Murata A.: Virocidal activity of vitamin C: Vitamin C for prevention and treatment of viral diseases. Proceedings of the First Intersectional Congress of Microbiological Societies, Science Council of Japan 1975, 3:432-442
151. Mutschler E.: Arzneimittelwirkungen. Lehrbuch der Pharmakologie und Toxikologie. Wissenschaftliche Verlagsgesellschaft mbH Stuttgart 1996
152. Myasnikova I.A.: Effect of ascorbic acid, nicotinic acid, and thiamine on cholesterolemia. Voenno-Morskoi Medical Academy Leningrad 1947; 8:140
153. Nath J., Gallin J.I.: Effect of vitamin C on tubulin tyrosinolation in polymorphonuclear leukocytes. Ann. N. Y. Acad. Sci. 1987; 498: 216-227
154. Naylor G.J., Smith A.H.W.: Vanadium: A possible aetiological factor in manic depressive illness. Psychological Medicine 1981, 11:249-256
155. Nyyssönen K. et al.: Vitamin C defiency and risk of myocardial infarction: prospective population study of men from eastern finland. Brit. Med. J. 1997; 314: 634-638
156. Oberritter H. et al.: Effect of functional stimulation on ascorbate content in phagocytes under physiological and pathologcal conditions. Int. Archs. Allergy. Appl. Immun. 1986; 81: 46-50.
157. Oda A., Bannai C., Yamaoka T., Katori T., Matsushima T., Yamashita K.: Inactivation of Cu, Zn-superoxide dismutase by in vitro glycosylation and in erythrocytes of diabetic patients. Horm. Metab. Res. 1994; 26:1-4
158. Ohlenschläger G.: Essentielle Nahrungsbestandteile. Orthomolekulare Prävention und orthomolekulare Therapien. Das Vitamin C In: Journal für orthomolekulare Medizin 1995; 2/95
159. Padmore Ian D. et al.: Vitamin C exhibite pro-oxidant properties. Nature 1998; 592/559
160. Paganelli G.M. et al.: Effect of vitamin A, C and E supplementation on rectal cell proliferation in patients with colocteral adenomas. 1992, Journal of the National Cancer Institute, 84(1) January 1992, p. 47-51
161. Paolisso G. et al.: Metabolic benefits deriving from chronic vitamin C supplementation in aged non-insulin dependent diabetes. J. Am. Coll. Nutrit. 1995; 14(4), 387-392
162. Pauling L. et al.: Apoprotein (a) is an adhesive protein. Journal of orthomolecular Medicine 991; 6:129-143
163. Pauling L.: Das Vitamin-Programm; Mindell, E. Die Vitamin Bibel; Roche Lexikon Medizin Urban & Schwarzenberg
164. Pauling L.: How to live longer and feel better. 1986
165. Petersen E.: In: Ärzte-Zeitung vom 26.1.1999
166. Plotnick G.D. et al.: JAMA 1997; 278/1682
167. Prinz W., Bortz R., Bragin B., Hersch M.: The effect of ascorbic acid supplementation on some parameters of the human immunological defence system. International Journal of Vitamin and Nutrition Research 1977; 47:248-256
168. Pugh D.M., Sharma S.C., Wilson C.W.M.: Inhibitory effect of L-ascorbic acid on the yield of prostaglandin F from the guinea-pig uterine homogenates. British Journal of Pharmacolocy 1975; 53:469 P
169. Rafsky H.A., Newman, B.: 1948, Geriatrics 3:267
170. Ramirez J. et al.: Leukocyte ascorbic acid and ist relationship to coronary artery disease in man. 1980, Amer.J.Clin.Nutr. 33: 2079-2088
171. Reed P.: Vitamin C, Heliobacter pylori infection and gastric carcinogenesis. Vortrag anläßlich des 5. Intern. Symposiums der angewandten Vitaminforschung am 15.5.1998 in Bonn
172. Reed P.I. et al.: Effect of ascorbic acid on the intragastric environment in patients at increased risk of developing gGastric cancer. 1991, LARC Sci Publ. (105) p. 139-142
173. Reuler J.B. et al.: Adult scurvy. J. Am. Med. Assoc. 1985; 253: 805-807
174. Rhoads G.C., Gulbrandsen C.L., Kagan, A.: Serum lipoproteins and coronary heart disease in a population study of hawaiian japanese men. New England Journal of Medicine 1976; 294:297.
175. Ritzel G.: Kritische Beurteilung des Vitamin C als Prophylaktikum und Therapeutikum der Erkältungskrankheiten. Helv. Med. Acta 1961; 28: 63-68
176. Rivers J.M.: Oral contraceptives and ascorbic acid. 1975, American Journal of Clinical Nutrition 28:550-554
177. Rock C.L., Jacob R.A., Bowen P.E.: Update on the biological characteristics of the antioxidant micronutrients: vitamin C, vitamin E, and the carotenoids. J. Am. Dietetic Assoc. 1996; 96, 7: 693-702
178. Rothmann K.J.: Vitamin C and reduced mortality. Epidemiology 1992; 3/189
179. Rüffer A., Beckmann G., Balles J.: Heliobacter pylori ö mikrobiologische Revolte im Magen. In: Journal für Orthomolekulare Medizin 7; 3 (1999)
180. Sabiston B.H., Radomski N.W.: Health problems and vitamin C in canadian northern military operations. Defence and Civil Institute of Environmental Medicine Report 1974; 74:1021
181. Samitz M.H. et al.: Ascorbic acid in the prevention of chrome dermatitis. 1968, Arch.Environ.Health 17/44-45
182. Sayed S.M., Roy P.B., Acharya P.T.: Leukocyte ascorbic acid and wound infection. 1975, Journal of the Indian Medical Association 64:120-123
183. Schorah C.J.: Vitamin C status in population groups. In: Vitamin C. Counsell, J.N., Hornig, D.H. Applied Science Publ. London 1981
184. Schünke G., Kuhlmann D., Lau W.: Orthomolekulare Medizin, Vitamine, Mineralstoffe, Spurenelemente. 1997, Hippokrates-Verlag, Stuttgart
185. Shibata A. et al.: Intake of vegetables, fruits, beta carotene, vitamin C and vitamin supplements and cancer incidence among the elderly: A prospective study. 1992, British Journal of Cancer 66(4) October 1992, p. 673-679
186. Sies M., Stahl W.: Vitamine E and C, beta-carotene, and other carotenoids as antioxidants. Am. J. Clin. Nutr. 1995; 62, 6 (Suppl): 1315-1321
187. Simon J.A.: Vitamin C and cardiovascular disease: a review. J. Amer. Coll. Nutr. 1992; 11 /107-125
188. Singh R.B., Niaz M.A., Rastogi S.S., Rastogi S.: Usefullness of antioxidant vitamins in suspected acute myocardial infarction (the Indian experiment of infarct survival-3). Am. J. Cardiol. 1996; 77, 4: 232-236
189. Sokoloff B., Hori M., Saelhoff C.C., Wrzolek T., Imai T.: Aging, atherosclerosis and ascorbic acid metabolism. Journal of the American Gerontology Society 1966;14:1239-1260
190. Stahelin H.B. et al.: Plasma antioxidant vitamins and subsequent cancer mortality in the 12-year follow-up of the prospective Basel study, 1991, Amer. J. of Epidemiology, 133(8), April 15, p. 766-775
191. Stone I.: The healing factor: Vitamin C against disease. 1972, Grosset and Dunlap, New York
192. Sukolinskii V.N., Morozkina T.S.: Prevention of postoperative complications in patients with stomach cancer using an antioxidant complex. 1989, Vopr Onkol, 35 (10) p. 1242-1245
193. Sullivan J.F., Eisenstein A.B.: Ascorbic acid depletion in patients undergoing chronic hemodialysis. Am. J. Clin. Nutr. 1970; 23:1339-1341
194. Tayler T.V., Rimmer S., Day B., Butcher J., Dymock I.W.: Ascorbic acid supplementation in the treatment of pressure-sores. 1974, The Lancet, 7.September, 544-546
195. Taylor A., Jaques P.F., Epstein E.M.: Relations among aging, antioxidant status, and cataract. Am. J. Clin. Nutr. 1995; 62, 6 (Suppl): 1439-1447.
196. Thomas S.R., Neuzil J., Mohr D., Stocker, R.: Coantioxidants make alpha-tocopherol an efficient antioxidant for low-density lipoprotein. Am. J. Clin. Nutr. 1995; 62, 6 (Suppl): 1357-1364
197. Universität Rotterdam & Netherland Institute of Health Sciences: Am. J. Epid 1999; 149:306
198. Vallance S.: Relationships between ascorbic acid and serum proteins of the Immune system. British Med. J. 1977; 2: 437-438
199. VanEenwyk J.: The Role of vitamins in the development of cervical cancer. 1993, The Nutrition Report 11(1) January, p. 1-8
200. Varreault X., et al.: A case-control study of diet and invasive cervical canver. 1989, Intern. J. of Cancer, 43(6) June 15, p.1050-1054
201. Virno M., Bucci M.G., Pecori-Giraldi J., Missiroli A.: Oral treatment of glaucoma with vitamin C. The Eye, Ear, Nose and Throat Monthly 1967; 46:1502-1508
202. Vita J.A. et al.: Lancet 9195, 1999, 2048
203. Wang Jin, Whetsell Michael, Klein John R.: Local hormone networks and intestinal T cell homeostasis. Science 1997; 275:1937-1939
204. Weber CH.: Vitamin C wirkt bei Rauchern antiatheresklerotisch. 1996, Circulation 93, 1488
205. Weissburger JH.: Causes of gastric and esophageal cancer. Possible approach to prevention by vitamin C. In: Nutritions and therapeutic agents 1985; S381-402
206. Willis G.C., Fishmann S.: Ascorbic acid content of human arterial tissue. Canadian Medical Association Journal, 1955, 72: 500-503; Sokoloff, B., Hori, M., Saelhof, C.C., Wrzolek, T., Imai, T.: Aging artherosclerosis, and ascorbic acid aetabolism. 1966, Journal of the American Geriatric Society: 14:1239-1260
207. Wintermayer U.: Vitamin C. Deutscher Apotheker Verlag Stuttgart 1985
208. Wolfram G.: Ist der Wert der antioxidativen Vitamine etabliert? Internist 1994; 35:1117-1123
209. Wynn A., Wynn M.: The effects of food shortage on human reproduction. Nutrition and Health 1993; 9:43-52
210. Yonemoto R.H., Chretien P.B., Fehniger T.F.: Enhanced lymphocyte blastogenesis by oral ascorbic acid. Proceedings of the American Association for Cancer Research 1976; 17:288). Yonemoto, R.H.: Vitamin C and the immunological response in normal controls and in cancer patients. Medico Dialogo 1979; 5:23-30.
211. You W.-C., Blot W.J., Chang Y.-S., Ershow A.G., Yang Z.-T., An Q., Henderson B., Xu G.-W., Fraumeni J.F., Wang T.-G.: Diet and high risk of stomach cancer in Shandong, China. Cancer research 1988; 48: 3518-3523
212. Yuan J.M., et al.: Diet and breast cancer in Shanghai and Tianjin, China. 1995, British Journal of Cancer, 71, p. 1353-1358
213. Zollinger P. et al.: Sudeck-Syndrom, Lancet 1999; 354: 2025.
214. Ziemann B., Enzmann F.: Vitamin C Ascorbinsäure, Ein lebensnotwendiger Schutzfaktor, 1998, MSE Pharmazeutika